Imagen de Portada

Unmet treatment needs in migraine: Results of the OVERCOME (US) study

Fuente: Wiley Open Access

Guardado en:

Detalles Bibliográficos
Autores principales:	Susan Hutchinson, Elizabeth Johnston, Robert A. Nicholson, Michael L. Reed, Dawn C. Buse, Anthony Zagar, Gilwan Kim, E. Jolanda Muenzel, Eric M. Pearlman, Richard B. Lipton
Formato:	Artículo Open Access
Publicado:	Wiley 2026
Materias:	Headache: The Journal of Head and Face Pain
Acceso en línea:	Acceder al recurso
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Rates and risk factors for migraine progression using multiple definitions of progression: Results of the longitudinal OVERCOME ( US ) study
por: Dawn C. Buse, et al.
Publicado: (2025)

Development of the Migraine‐Related Stigma (MiRS) Questionnaire: Results of the OVERCOME (US) Study
por: Elizabeth K. Seng, et al.
Publicado: (2025)

Reasons for patient reluctance to take preventive medications for migraine: Results of the OVERCOME ( US ) study
por: Jessica Ailani, et al.
Publicado: (2026)

Characterizing gaps in the preventive pharmacologic treatment of migraine: Multi‐country results from the CaMEO‐I study
por: Dawn C. Buse, et al.
Publicado: (2024)

Prevalence and burden of migraine in the United States: A systematic review
por: Fred Cohen, et al.
Publicado: (2024)

The impacts of migraine on functioning: Results from two qualitative studies of people living with migraine
por: Rikki Mangrum, et al.
Publicado: (2024)

What a long strange trip it's been: Reflections on serial snapshots of migraine prevalence and burden in the United States
por: Fred Cohen, et al.
Publicado: (2025)

Challenges and opportunities for estimating and assessing migraine prevalence, incidence and impact across study populations and methodologies: Bridging global and United States findings
por: Fred Cohen, et al.
Publicado: (2024)

A 3‐year follow‐up study of outcomes associated with patterns of traditional acute and preventive migraine treatment: An administrative claims‐based cohort study in the United States
por: Shivang Joshi, et al.
Publicado: (2024)

Rates and healthcare resource utilization for people with branded acute and preventive migraine prescription medication order payer denials: An open, multi‐source dataset, observational cohort study
por: Dawn C. Buse, et al.
Publicado: (2026)

Integrating gepants into clinical practice for the acute treatment of migraine
por: Richard B. Lipton, et al.
Publicado: (2026)

A 52‐week open‐label extension study to evaluate the safety and efficacy of oral rimegepant for the preventive treatment of migraine
por: David Kudrow, et al.
Publicado: (2025)

Patient preferences for the preventive treatment of episodic migraine in the United States: A discrete‐choice experiment
por: Richard B. Lipton, et al.
Publicado: (2025)

Vaporized cannabis versus placebo for acute migraine: A randomized, double‐blind, placebo‐controlled crossover trial
por: Nathaniel M. Schuster, et al.
Publicado: (2025)

Comparative analysis of real‐world acute prescription migraine therapy outcomes: Insights from the HeAD – US study
por: Devin Teichrow, et al.
Publicado: (2026)

Behavioral interventions for migraine prevention: A systematic review and meta‐analysis
por: Jonathan R. Treadwell, et al.
Publicado: (2025)

Treatment effectiveness of galcanezumab versus traditional oral migraine preventive medications at 3 months: Results from the TRIUMPH study
por: Richard B. Lipton, et al.
Publicado: (2025)

Real‐world barriers to health care utilization among people living with migraine: Insights from the All of Us Research Program
por: Idris Demirsoy, et al.
Publicado: (2025)

Sustained benefits of onabotulinumtoxinA treatment in chronic migraine: An analysis of the pooled Phase 3 REsearch Evaluating Migraine Prophylaxis Therapy (PREEMPT) randomized controlled trials
por: Stephen D. Silberstein, et al.
Publicado: (2024)

Microneedles for the treatment of migraine and orofacial pain: A narrative review
por: Baicheng Cao, et al.
Publicado: (2026)

Partial rebreathing is not effective for early treatment of migraine with aura attacks: Results of a double‐blind, randomized, controlled trial ( PAREMA1 )
por: Charly Gaul, et al.
Publicado: (2025)

Advancing toward precision migraine treatment: Predicting responses to preventive medications with machine learning models based on patient and migraine features
por: Chia‐Chun Chiang, et al.
Publicado: (2024)

Characterizing the patient experience during the prodrome phase of migraine: A qualitative study of symptoms and their timing
por: Richard B. Lipton, et al.
Publicado: (2025)

Navigating the patient journey in migraine prevention: An American Migraine Foundation position paper
por: Lawrence C. Newman, et al.
Publicado: (2025)

Delayed urticaria during treatment with anti‐ CGRP monoclonal antibodies in migraine
por: Christoph T. Berger, et al.
Publicado: (2026)

Cost per treatment responder analysis of atogepant compared to rimegepant for the preventive treatment of episodic migraine
por: Jessica Ailani, et al.
Publicado: (2024)

Genetic migraine disorders and the response to calcitonin gene‐related peptide antagonist treatment
por: Andrea M. Kuczynski, et al.
Publicado: (2025)

Rising migraine incidence in adolescents despite stable prevalence in the US : A call for further investigation
por: Ali Reza Tavasoli, et al.
Publicado: (2024)

Long‐term effectiveness of eptinezumab in the treatment of patients with chronic migraine and medication‐overuse headache
por: Andrew Blumenfeld, et al.
Publicado: (2024)

Mapping the migraine: Intracranial recording of cortical spreading depression in migraine with aura
por: Graham A. McLeod, et al.
Publicado: (2025)

Response to: Disagreement with Categorization of Clinical Trials included in Treadwell et al. Systematic Review and Meta‐Analysis
por: Jonathan R. Treadwell, et al.
Publicado: (2025)

Routine migraine screening as a standard of care for Women's health: A position statement from the American Headache Society
por: Todd J. Schwedt, et al.
Publicado: (2025)

Patient preferences for preventive migraine treatments among Canadian adults: A discrete choice experiment
por: Joanna K. Bougie, et al.
Publicado: (2024)

Do patients with migraine and obesity receive different treatments? Insights from real‐world data
por: Keshet Pardo, et al.
Publicado: (2025)

Novel optimization of multi‐mechanistic approaches for the acute treatment of a migraine attack: A review
por: Stephen Silberstein, et al.
Publicado: (2026)

The impact of the migraine treatment onabotulinumtoxinA on inflammatory and pain responses: Insights from an animal model
por: Philip Victor Reducha, et al.
Publicado: (2024)

The effect of different exercise types on migraine frequency in individuals with migraine: A pilot study
por: Yunus Emre Meydanal, et al.
Publicado: (2025)

No association between migraine and HLA alleles in a cohort of 13,210 individuals with migraine from the Danish Blood Donor Study
por: Inga Zalia Tummoszeit, et al.
Publicado: (2024)

Randomized controlled trial of intravenous dexamethasone to prevent relapse in the treatment of migraine in a pediatric emergency department
por: Geneviève Tourigny‐Ruel, et al.
Publicado: (2026)

Correction to “Smartphone‐delivered progressive muscle relaxation for the treatment of migraine in primary care: A randomized controlled trial”
Publicado: (2025)